Fever & Acute Responses — Fever and acute responses (overview)

Historical Context & Motivation

Throughout most of medical history, fever was regarded not as a symptom of disease but as the disease itself. Ancient physicians from Hippocrates to Galen described fever as an imbalance of the four humors — an excess of yellow bile generating heat within the body. This humoral framework dominated Western medicine for nearly two millennia, and therapeutic interventions centered on bloodletting and purgation to restore equilibrium. It was not until the rise of experimental physiology in the nineteenth century that investigators began to suspect fever was an active, regulated physiological process rather than a passive consequence of pathology. Understanding this shift is essential to appreciating how modern immunology conceptualizes the acute-phase response as a coordinated, host-protective program.

The central question that drove this century of research remains the organizing principle of this lesson: How does the host mount a rapid, systemic defense in the first hours to days after encountering a pathogen, and what molecular circuitry connects microbial recognition to elevated body temperature, altered plasma protein composition, and recruitment of inflammatory cells? These phenomena — collectively termed the fever and acute-phase response — represent one of the oldest and most conserved arms of innate immunity.

Core Principles & Definitions

The acute-phase response is a complex, multi-organ reaction initiated within hours of tissue injury or infection. Rather than a single pathway, it involves a cascade of events that begins with local recognition of pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) by sentinel immune cells, progresses through cytokine signaling, and culminates in systemic physiological changes including fever, hepatic acute-phase protein synthesis, leukocytosis, and behavioral modifications such as anorexia and somnolence. Four foundational principles anchor the biology of this response.

Visual Explanation — The Fever Pathway

The pathway depicted above illustrates a critical distinction between exogenous pyrogens and endogenous pyrogens. Exogenous pyrogens are microbial products — lipopolysaccharide (LPS) from Gram-negative bacteria being the prototypical example — that are recognized by pattern-recognition receptors (PRRs) such as Toll-like receptor 4 (TLR4). Upon engagement, intracellular signaling cascades activate NF-κB, leading to transcription and secretion of the classic pyrogenic cytokines. These endogenous pyrogens then reach the organum vasculosum of the lamina terminalis (OVLT), a circumventricular organ lacking a complete blood–brain barrier, where they stimulate perivascular cells to produce PGE₂ via the COX-2 enzyme. PGE₂ binds EP3 receptors on thermoregulatory neurons in the preoptic area, raising the thermostat's set-point and triggering effector mechanisms — peripheral vasoconstriction conserves heat, shivering generates heat, and the patient experiences chills until core temperature reaches the new set-point.

Molecular Mechanisms of the Acute-Phase Response

While fever is the most clinically obvious manifestation of the acute-phase response, the underlying molecular machinery orchestrates changes across multiple organ systems simultaneously. This section examines the signaling cascades and effector mechanisms in greater depth, emphasizing the role of cytokine networks and the hepatic acute-phase protein program.

Cytokine Signaling Cascades

The three principal pyrogenic cytokines — IL-1β, TNF-α, and IL-6 — have overlapping but distinct roles. IL-1β and TNF-α are early-response cytokines produced rapidly by macrophages upon TLR engagement; they act in an autocrine/paracrine fashion to amplify local inflammation and also reach the systemic circulation. IL-6 production is stimulated in part by IL-1β itself, creating a feed-forward loop. Importantly, IL-6 is the dominant inducer of the hepatic acute-phase response, acting through the JAK-STAT3 signaling pathway in hepatocytes. This cascade drives the transcription of positive acute-phase proteins — those whose serum concentrations rise — while simultaneously suppressing negative acute-phase proteins such as albumin and transferrin. The net result is a reprogramming of hepatic protein output toward immune defense.

PGE₂ Synthesis — The Final Common Pathway

Thermoregulatory Set-Point Elevation

The preoptic area of the anterior hypothalamus functions as the body's thermostat. Under normal conditions, warm-sensitive neurons fire at rates proportional to core temperature, driving heat-dissipation responses when temperature exceeds the set-point (≈37 °C). PGE₂ binding to EP3 receptors inhibits the firing of these warm-sensitive neurons, effectively raising the set-point. The hypothalamus now interprets normal body temperature as 'too cold,' triggering heat conservation (cutaneous vasoconstriction) and heat generation (shivering thermogenesis, increased metabolic rate). Body temperature climbs until it matches the new elevated set-point, typically in the range of 38–41 °C. When the pyrogen stimulus subsides — for example, as infection is controlled — PGE₂ levels fall, the set-point returns to normal, and heat-dissipation mechanisms (vasodilation, sweating) activate, producing defervescence.

Acute-Phase Proteins — Classification and Functions

The hepatic response to inflammatory cytokines produces a dramatic shift in the plasma protein profile. Acute-phase proteins (APPs) are defined as plasma proteins whose concentration changes by at least 25% during inflammation. Positive APPs increase and contribute to host defense through opsonization, complement activation, coagulation, and metal ion sequestration. Negative APPs decrease, reflecting the liver's reallocation of amino acids and synthetic machinery toward defensive protein production. The following diagram and table detail the major players and their immunological roles.

Worked Example — Interpreting an Acute-Phase Response

Consider the following clinical scenario: A 22-year-old college student presents to the university health center with a 2-day history of sore throat, fever (39.2 °C), malaise, and myalgia. A rapid strep test is positive for Group A Streptococcus pyogenes. Blood work reveals a white blood cell count of 14,500/μL (reference: 4,500–11,000/μL), CRP of 85 mg/L (reference: <5 mg/L), and serum albumin of 3.1 g/dL (reference: 3.5–5.5 g/dL). Let us trace the immunological logic of these findings step by step.

Fever — Adaptive Benefits vs. Pathological Risks

Fever is among the most evolutionarily conserved host responses, present in vertebrates and even some invertebrates and plants. This deep conservation suggests strong selective pressure favoring febrile organisms — yet fever also carries metabolic costs and, at extreme temperatures, tissue damage. Understanding this trade-off is clinically relevant because it informs decisions about whether and when to administer antipyretic therapy.

Connection to Advanced Immunology — From Innate to Adaptive

The fever and acute-phase response, while classified under innate immunity, profoundly influences the subsequent adaptive immune response. This bridging function positions the acute-phase response as a critical node in the larger network of host defense. Several advanced topics build directly upon the principles covered in this overview.

As you progress through microbiology and immunology coursework, you will encounter these advanced topics as natural extensions of the fever and acute-phase framework. The cytokine network introduced here — IL-1β, TNF-α, and IL-6 — reappears throughout adaptive immunity, autoimmune disease, and even cancer immunology. Mastery of the signaling logic in this lesson (PAMP → PRR → NF-κB → cytokines → hypothalamic PGE₂ → fever; IL-6 → JAK-STAT3 → APPs) will serve as a conceptual scaffold onto which more complex material can be built.

Practice Problems

Lesson Summary